Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
Pediatr Rheumatol Online J
; 18(1): 2, 2020 Jan 10.
Article
in En
| MEDLINE
| ID: mdl-31924225
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arthritis, Juvenile
/
Antirheumatic Agents
/
Macrophage Activation Syndrome
/
Antibodies, Monoclonal, Humanized
Type of study:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Child
/
Child, preschool
/
Female
/
Humans
/
Male
Language:
En
Journal:
Pediatr Rheumatol Online J
Year:
2020
Document type:
Article
Affiliation country:
Japan
Country of publication:
United kingdom